You're invited:

A New Way to Connec+! 

BIOTECanada is pleased to present Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies.

The next Bio+ech Connec+ will take place on Thursday, May 5th featuring AbbVie.

This virtual forum will include a plenary session led by Henry Gosebruch, Executive Vice President, Chief Strategy Officer, AbbVie, and Tracey Ramsay, Vice President & General Manager, AbbVie Canada. They will share an overview of the company, its R&D priorities including its pipeline and corresponding investment priorities for the period ahead.

Henry Gosebruch is responsible for corporate strategy, business development and acquisitions, search and evaluation, alliance management and AbbVie Ventures. Since joining AbbVie in December 2015, Mr. Gosebruch and his team have completed more than 75 partnering, collaboration, mergers & acquisitions (M&A) and venture transactions to bolster AbbVie’s commercial franchises and pipeline of innovative preclinical and clinical development programs, working closely with AbbVie colleagues globally.

AbbVie representatives will then engage in a Q&A session with the plenary audience. Following the plenary and Q&A, a select group of early-stage companies will be provided an opportunity to connect bilaterally with the AbbVie representatives.

Thursday, May 5th
11:00 am - 12:15 pm ET 

Plenary Session

Plenary and Q&A will run 11:00 - 12:15 ET. The opening plenary/Q&A session is open to all to participate at no cost. Save your spot by registering today!

Bilateral Meetings

If you would like to participate in a 30-minute one-on-one meeting session with AbbVie representatives following the plenary, please apply by Friday, April 15. You will be notified if you have secured a meeting by Wednesday, April 27th. (The application process is quick and painless!).

Therapeutic areas of focus for AbbVie includes:
Oncology | Immunology | Neuroscience | Eye care | Aesthetics | Virology | Cystic fibrosis | Women's Health | Platforms and technologies

To learn more about the therapeutic areas of interest for AbbVie, please refer to this brochure, pages 8-10 in particular.

Note: Plenary and Q&A will run approx. 11:00-12:15 PM. If selected, your 30-minute meeting will occur at some point after 12:30 PM (ET) on May 5th.

Apply here by April 15th